Search

Your search keyword '"Besi, Francesca"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Besi, Francesca" Remove constraint Author: "Besi, Francesca"
36 results on '"Besi, Francesca"'

Search Results

2. Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting

6. The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity

8. The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity.

11. Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity

12. MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells.

13. Additional file 1 of Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma

14. Additional file 3 of Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma

15. Additional file 6 of Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma

16. Additional file 4 of Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma

17. Additional file 2 of Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma

18. Additional file 5 of Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma

22. Glucocorticoids and the cytokines IL-12, IL-15, and IL-18 present in the tumor microenvironment induce PD-1 expression on human natural killer cells

24. Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting

26. Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting

27. Proteasome Inhibitors Impair the Innate Antiviral Immune Response and Potentiate Pelareorep-Based Viral Therapy in Multiple Myeloma

28. PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation

29. In Human Immunodeficiency Virus primary infection, early combined antiretroviral therapy reduced γδ T‐cell activation but failed to restore their polyfunctionality

30. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing

31. Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD‐1 receptor

32. PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression

33. HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection

34. Vγ9Vδ2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell Count

35. PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression.

36. HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection.

Catalog

Books, media, physical & digital resources